Singapore markets close in 41 minutes

GlaxoSmithKline plc (GSK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
45.74+1.59 (+3.60%)
At close: 04:00PM EST
45.74 0.00 (0.00%)
After hours: 07:57PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 110.90B
Enterprise value 140.73B
Trailing P/E 19.20
Forward P/E 13.85
PEG Ratio (5 yr expected) 3.54
Price/sales (ttm)2.48
Price/book (mrq)5.33
Enterprise value/revenue 4.22
Enterprise value/EBITDA 12.74

Trading information

Stock price history

Beta (5Y monthly) 0.38
52-week change 318.52%
S&P500 52-week change 317.11%
52-week high 346.86
52-week low 333.53
50-day moving average 343.33
200-day moving average 340.63

Share statistics

Avg vol (3-month) 34.16M
Avg vol (10-day) 35.65M
Shares outstanding 52.52B
Implied shares outstanding 6N/A
Float 82.45B
% held by insiders 10.01%
% held by institutions 113.21%
Shares short (13 Jan 2022) 49.53M
Short ratio (13 Jan 2022) 42.79
Short % of float (13 Jan 2022) 4N/A
Short % of shares outstanding (13 Jan 2022) 40.38%
Shares short (prior month 14 Dec 2021) 410.41M

Dividends & splits

Forward annual dividend rate 42.2
Forward annual dividend yield 44.98%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 31.81%
5-year average dividend yield 45.23
Payout ratio 493.50%
Dividend date 312 Jan 2022
Ex-dividend date 417 Nov 2021
Last split factor 22:1
Last split date 311 Nov 1991

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin 12.94%
Operating margin (ttm)24.78%

Management effectiveness

Return on assets (ttm)6.47%
Return on equity (ttm)23.62%

Income statement

Revenue (ttm)33.33B
Revenue per share (ttm)13.34
Quarterly revenue growth (yoy)5.00%
Gross profit (ttm)23.21B
EBITDA 10.23B
Net income avi to common (ttm)4.31B
Diluted EPS (ttm)2.30
Quarterly earnings growth (yoy)-6.10%

Balance sheet

Total cash (mrq)3.51B
Total cash per share (mrq)1.4
Total debt (mrq)25.6B
Total debt/equity (mrq)117.74
Current ratio (mrq)0.81
Book value per share (mrq)6.16

Cash flow statement

Operating cash flow (ttm)8.04B
Levered free cash flow (ttm)8.77B